Sign In to Follow Application
View All Documents & Correspondence

Stable And Sensorially Superior Topical Formulation

Abstract: STABLE AND SENSORIALLY SUPERIOR TOPICAL FORMULATION The instant disclosure provides a stable and sensorially superior (non-patchy, non oily/greasy, easily spreadable etc.) topical preparation with zinc oxide and boric acid as skin beneficiary actives in the form of emulsion with the combination of thickeners, humectants, oil components (hydrocarbons, emollients, bodying agents) and non-ionic emulsification system at a particular concentration. The present disclosure also relates to a process of preparation stable topical formulation.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
24 January 2017
Publication Number
30/2018
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
iprdel@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2022-09-09
Renewal Date

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India

Inventors

1. KIRUBAKARAN, Balavaishnavi
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
2. MURALI, Deepa
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
3. PASUPULATE, Sravanthi
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India

Specification

Claims:1. A stable topical formulation comprising:
a) zinc oxide;
b) boric acid;
c) steareth 21;
d) steareth 2;
e) at least one non-ionic thickener;
f) at least one silicone; and
g) at least one oil component,
wherein the steareth 21 to the steareth 2 weight ratio is in the range of 1:0.3-1:3.
2. The formulation as claimed in claim 1, wherein the silicone is selected from the group consisting of dimethicone, polysilicone-11, phenyl trimethicone, trimethylsilylamodimethicone, stearoxytrimethylsilane, cyclomethicone, hexamethyldisiloxane, octamethyltrisiloxane, decamethylpentacyclosiloxane, dialkenylsilicones, dialkylsilicones, diaryl silicones, alkylarylsilicones, alkenylalkylsilicones, and mixtures thereof.
3. The formulation as claimed in claim 2, wherein the silicone is dimethicone.
4. The formulation as claimed in claim 1, wherein the oil component comprises at least one hydrocarbon, at least one emollient, and combinations thereof.
5. The formulation as claimed in claim 4, wherein the hydrocarbon is selected from the group consisting of petrolatum, paraffin wax, mineral oil, and combinations thereof.
6. The formulation as claimed in claim 4, wherein the emollient is selected from the group consisting of squalene, cyclopentasiloxane, dimethicone, derivatives, isopropyl myristate, isopropyl palmitate, isopropyl isostearate, C12-15 alkyl benzoate, fatty alcohols, and combinations thereof.
7. The formulation as claimed in claim 1, wherein the non-ionic thickener is selected from the group consisting of xanthan gum, guar gum, gum arabic, and combinations thereof.
8. The formulation as claimed in claim 7, wherein the non-ionic thickener is xanthan gum.
9. The formulation as claimed in claim 1, wherein the formulation has a pH in the range of 7.0-8.0.
10. A stable topical formulation comprising:
a) zinc oxide having a weight percentage in the range of 0.5-3% with respect to the formulation;
b) boric acid having a weight percentage in the range of 0.5-5% with respect to the formulation;
c) steareth 21 having a weight percentage in the range of 0.9-2.7% with respect to the formulation;
d) steareth 2 having a weight percentage in the range of 0.9-2.7% with respect to the formulation;
e) at least one non-ionic thickener having a weight percentage in the range of 0.5-0.75% with respect to the formulation;
f) at least one silicone having a weight percentage in the range of 2-3% with respect to the formulation; and
g) at least one oil component having a weight percentage in the range of 20-30% with respect to the formulation,
wherein the steareth 21 to the steareth 2 weight ratio is in the range of 1:0.3-1:3.
11. A process for the preparation of a stable topical formulation as claimed in claim 1, comprising steps of:
a) contacting at least one non-ionic thickener and water to obtain water phase;
b) contacting at least one oil component with steareth 21 and steareth 2 to obtain oil phase;
c) contacting the water phase and the oil phase followed by homogenization to obtain a first mixture; and
d) contacting zinc oxide and boric acid with first mixture to obtain stable topical formulation,
wherein steareth 21 to steareth 2 weight ratio is in the range of 1:0.3-1:3.
12. The process as claimed in claim 11, comprising steps of:
a) contacting at least one non-ionic thickener and water to obtain a dispersion, followed by heating the dispersion till the dispersion attains a a temperature in the range of 70 - 75 °C to obtain a water phase;
b) contacting at least one oil component with steareth 21 and steareth 2 followed by heating the mixture at a temperature in the range of 70-75 0C to an obtain oil phase;
c) contacting the water phase and the oil phase at a temperature in the range of 70-75 0C followed by homogenization for a period in the range of 5-30 minutes at a stirring speed in the range of 5000-7000 rpm to obtain a first mixture; and
d) contacting zinc oxide and boric acid with the first mixture, followed by stirring at a speed in the range of 70-75 rpm at a temperature in the range of 25-30 0C to obtain stable topical formulation.
, Description:As Attached

Documents

Application Documents

# Name Date
1 Form 5 [24-01-2017(online)].pdf 2017-01-24
2 Form 3 [24-01-2017(online)].pdf 2017-01-24
3 Description(Complete) [24-01-2017(online)].pdf_321.pdf 2017-01-24
4 Description(Complete) [24-01-2017(online)].pdf 2017-01-24
5 Other Patent Document [20-03-2017(online)].pdf 2017-03-20
6 Form 26 [20-03-2017(online)].pdf 2017-03-20
7 Correspondence by Agent_Proof of Right-Form1_22-03-2017.pdf 2017-03-22
8 Correspondence by Agent_Power of Authorisation_22-03-2017.pdf 2017-03-22
9 201741002765-FORM 18 [19-01-2021(online)].pdf 2021-01-19
10 201741002765-Response to office action [20-09-2021(online)].pdf 2021-09-20
11 201741002765-FER.pdf 2021-10-17
12 201741002765-OTHERS [05-05-2022(online)].pdf 2022-05-05
13 201741002765-FORM 3 [05-05-2022(online)].pdf 2022-05-05
14 201741002765-FER_SER_REPLY [05-05-2022(online)].pdf 2022-05-05
15 201741002765-PatentCertificate09-09-2022.pdf 2022-09-09
16 201741002765-IntimationOfGrant09-09-2022.pdf 2022-09-09

Search Strategy

1 SearchreportE_22-03-2021.pdf

ERegister / Renewals

3rd: 28 Nov 2022

From 24/01/2019 - To 24/01/2020

4th: 28 Nov 2022

From 24/01/2020 - To 24/01/2021

5th: 28 Nov 2022

From 24/01/2021 - To 24/01/2022

6th: 28 Nov 2022

From 24/01/2022 - To 24/01/2023

7th: 28 Nov 2022

From 24/01/2023 - To 24/01/2024

8th: 11 Jan 2024

From 24/01/2024 - To 24/01/2025

9th: 07 Nov 2024

From 24/01/2025 - To 24/01/2026